ExpreS2ion Biotech Holding AB: Publication of financial report for January – September 2018
ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby publishes the financial report for the period of January – September 2018. The report is available as an attached document to this press release and on the Company’s website (www.expres2ionbio.com). Below is a summary of the report.Q3 (2018-07-01 to 2018-09-30) · Group turnover amounted to 2,173 (2,048) KSEK. · Result after financial items amounted to -5,197 (-3,311) KSEK. · Net income amounted to -4,698 (-2,955) KSEK. · Net income per share* amounted to -0.39 (-0.33) SEK. Nine months (2018-01-01 to 2018-09-30) ·